Patents by Inventor Eric Law

Eric Law has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10881342
    Abstract: An assembly for sampling bodily fluid, the assembly comprising a membrane penetration device comprising a membrane penetrating element for penetrating a bodily membrane to release a bodily fluid; and, a collector configured in a collection position to take up the released bodily fluid and retain the fluid for delivery to a test element.
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: January 5, 2021
    Assignee: ATOMO DIAGNOSTICS PTY LIMITED
    Inventors: John Kelly, Richard Sokolov, Ian Fredrick Johnson, Ernesto Monis Hueso, Eric Siu, Melody Shiue, Kamman Law, Johannes Behrisch
  • Patent number: 10884503
    Abstract: Methods, computing devices, and computer-program products are provided for implementing a virtual personal assistant. In various implementations, a virtual personal assistant can be configured to receive sensory input, including at least two different types of information. The virtual personal assistant can further be configured to determine semantic information from the sensory input, and to identify a context-specific framework. The virtual personal assistant can further be configured to determine a current intent. Determining the current intent can include using the semantic information and the context-specific framework. The virtual personal assistant can further be configured to determine a current input state. Determining the current input state can include using the semantic information and one or more behavioral models. The behavioral models can include one or more interpretations of previously-provided semantic information.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: January 5, 2021
    Assignee: SRI International
    Inventors: Ajay Divakaran, Amir Tamrakar, Girish Acharya, William Mark, Greg Ho, Jihua Huang, David Salter, Edgar Kalns, Michael Wessel, Min Yin, James Carpenter, Brent Mombourquette, Kenneth Nitz, Elizabeth Shriberg, Eric Law, Michael Frandsen, Hyong-Gyun Kim, Cory Albright, Andreas Tsiartas
  • Publication number: 20200402193
    Abstract: A computer apparatus, such as a validator node, for validating incident-related data records in a distributed electronic ledger is configured to receive a request from an agent to add a proposed incident-related data record associated with an incident to the distributed electronic ledger. In response to the proposed incident-related data record, the computer apparatus determines, from the distributed electronic ledger, one or more attributes of the agent or incident. The computer apparatus determines whether the proposed incident-related data record satisfies validation criteria based at least partially on the one or more attributes of the agent or incident. Once validated, the computer apparatus may then append the proposed incident-related data record to the distributed electronic ledger. Alternatively, the proposed incident-related data record may be appended regardless of validity, but an indication of validity may be appended if the proposed incident-related data record is validated.
    Type: Application
    Filed: September 8, 2020
    Publication date: December 24, 2020
    Inventors: FRANCESCA SCHULER, THOMAS S MESSERGES, BRADLEY M. HIBEN, DANIEL A LAW, ERIC JOHNSON
  • Patent number: 10803540
    Abstract: A computer apparatus, such as a validator node, for validating incident-related data records in a distributed electronic ledger is configured to receive a request from an agent to add a proposed incident-related data record associated with an incident to the distributed electronic ledger. In response to the proposed incident-related data record, the computer apparatus determines, from the distributed electronic ledger, one or more attributes of the agent or incident. The computer apparatus determines whether the proposed incident-related data record satisfies validation criteria based at least partially on the one or more attributes of the agent or incident. Once validated, the computer apparatus may then append the proposed incident-related data record to the distributed electronic ledger. Alternatively, the proposed incident-related data record may be appended regardless of validity, but an indication of validity may be appended if the proposed incident-related data record is validated.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: October 13, 2020
    Assignee: MOTOROLA SOLUTIONS, INC.
    Inventors: Francesca Schuler, Thomas S Messerges, Bradley M. Hiben, Daniel A Law, Eric Johnson
  • Publication number: 20200223536
    Abstract: An aircraft includes an airframe, an extending tail, a counter rotating, coaxial main rotor assembly including an upper rotor assembly and a lower rotor assembly, and a translational thrust system positioned at the extending tail. The translational thrust system provides translational thrust to the airframe. An upper hub fairing is positioned at the upper rotor assembly. A lower hub fairing is positioned at the lower rotor assembly. A shaft fairing is disposed between the upper hub fairing and the lower hub fairing. The upper hub fairing is substantially sealed to the shaft fairing and the lower hub fairing is substantially sealed to the shaft fairing.
    Type: Application
    Filed: March 27, 2020
    Publication date: July 16, 2020
    Inventors: Thomas Alan Egolf, Robert D. Beatty, Gary Law, Chris P. Butler, Eric Lucien Nussenblatt, Edward Reed
  • Patent number: 10599848
    Abstract: A system may be configured to receive via a user interface a user-initiated prompt to begin start-up of a computer system firmware via access to a firmware start-up utility. The system may also generate a request for user authentication, and detect a private key for user authentication. The system may also determine whether the private key corresponds to a public key previously registered with the computer system firmware, and initiate, when the private key corresponds to the public key, completion of the start-up of the computer system firmware and allowance of operation of the computer system firmware via access to the firmware start-up utility. When the private key does not correspond to the public key, the system may prevent at least one aspect of an operation associated with the start-up of the computer system firmware.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: March 24, 2020
    Assignee: American Megatrends International, LLC
    Inventors: Kai Yau, William Gysin, Eric Law
  • Publication number: 20200057453
    Abstract: Disclosed herein are a method and apparatus for automated following behind a lead vehicle. The lead vehicle navigates a path from a starting point to a destination. The lead vehicle and the following vehicle are connected via V2V communication, allowing one or more following vehicles to detect the path taken by the lead vehicle. A computerized control system on the following vehicle (a Follow-the-Leader, or FTL, system) allows the following vehicle to mimic the behavior of the lead vehicle, with the FTL system controlling steering to guide the following vehicle along the path previously navigated by the lead vehicle. In some embodiments, the lead vehicle and following vehicle may both use Global Navigation Satellite System (GNSS) position coordinates. In some embodiments, the following vehicle may also have a system of sensors to maintain a gap between the following and lead vehicles.
    Type: Application
    Filed: July 6, 2019
    Publication date: February 20, 2020
    Applicant: Peloton Technology, Inc.
    Inventors: Shad Laws, Joshua Switkes, Art Gavrysh, Marc Tange, Mark Herbert, Colleen Twitty, Dean Hogle, Andrew Tamoney, Eric Monsler, Carlos Rosario, Oliver Bayley, Richard Pallo, Louis Donayre, Laurenz Laubinger, Brian Smartt, Joyce Tam, Brian Silverman, Tabitha Jarvis, Murad Bharwani, Steven Erlein, Austin Schuh, Mark Luckevich
  • Publication number: 20190330592
    Abstract: Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection.
    Type: Application
    Filed: July 3, 2019
    Publication date: October 31, 2019
    Applicant: Celularity, Inc.
    Inventors: Robert J. HARIRI, Mohammad A. HEIDARAN, Stephen JASKO, Lin KANG, Eric LAW, Ajai PAL, Bhavani STOUT, Vanessa VOSKINARIAN-BERSE, Andrew ZEITLIN, Xiaokui ZHANG
  • Publication number: 20190287200
    Abstract: A computer apparatus, such as a validator node, for validating incident-related data records in a distributed electronic ledger is configured to receive a request from an agent to add a proposed incident-related data record associated with an incident to the distributed electronic ledger. In response to the proposed incident-related data record, the computer apparatus determines, from the distributed electronic ledger, one or more attributes of the agent or incident. The computer apparatus determines whether the proposed incident-related data record satisfies validation criteria based at least partially on the one or more attributes of the agent or incident. Once validated, the computer apparatus may then append the proposed incident-related data record to the distributed electronic ledger. Alternatively, the proposed incident-related data record may be appended regardless of validity, but an indication of validity may be appended if the proposed incident-related data record is validated.
    Type: Application
    Filed: March 14, 2018
    Publication date: September 19, 2019
    Inventors: FRANCESCA SCHULER, THOMAS S. MESSERGES, BRADLEY M. HIBEN, DANIEL A. LAW, ERIC JOHNSON
  • Publication number: 20180346877
    Abstract: Provided herein are methods of producing natural killer (NK) cells and/or ILC3 cells using a three-stage expansion and differentiation method with media comprising stem cell mobilizing factors. Also provided herein are methods of suppressing tumor cell proliferation using the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein, as well as methods of treating individuals having cancer or a viral infection, comprising administering the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein to an individual having the cancer or viral infection.
    Type: Application
    Filed: October 14, 2016
    Publication date: December 6, 2018
    Applicant: CELULARITY, INC.
    Inventors: Xiaokui ZHANG, Ivana DJURETIC, Lin KANG, Vanessa VOSKINARIAN-BERSE, Bhavani STOUT, Robert J. HARIRI, Wolfgang HOFGARTNER, James EDINGER, Eric LAW, Vladimir JANKOVIC
  • Publication number: 20180298328
    Abstract: Provided herein are stimulated placental stem cells and methods of treating individuals having diseases or disorders of the circulatory system using stimulated placental cells. The invention also provides methods of inducing angiogenesis using such stimulated cells or populations of cells comprising such stimulated cells.
    Type: Application
    Filed: May 25, 2016
    Publication date: October 18, 2018
    Applicant: Celularity, Inc.
    Inventors: Kathy E. KARASIEWICZ-MENDEZ, Aleksandar FRANCKI, Jeffrey TURNER, Eric LAW, Jennifer PAREDES, Kristen LABAZZO, Hemlata RANA, Wolfgang HOFGARTNER, Robert J. HARIRI
  • Publication number: 20180071343
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Application
    Filed: November 16, 2017
    Publication date: March 15, 2018
    Applicant: Celularity, Inc.
    Inventors: Stewart Abbot, James Edinger, Aleksander Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav Padliya, Jennifer Paredes, Jia-Lun Wang
  • Patent number: 9763983
    Abstract: Provided herein are placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, combined natural killer cells from placenta and umbilical cord blood, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, and combined natural killer cells and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells. Also provided herein are methods of treating an individual having a tumor or graft-versus-host disease with placental perfusate, placental perfusate-derived cells, natural killer cells from placenta, e.g., from placental perfusate, and/or combined natural killer cells comprising natural killer cells from placenta, e.g., from placental perfusate, and umbilical cord blood.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: September 19, 2017
    Assignee: ANTHROGENESIS CORPORATION
    Inventors: Xiaokui Zhang, Robert J. Hariri, Vanessa Voskinarian-Berse, Lin Kang, Eric Law, Stewart Abbot
  • Publication number: 20170252379
    Abstract: Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same. In one aspect, provided herein are compositions comprising exosomes produced by and/or derived from placental cells, e.g., placenta-derived adherent cells. In certain embodiments, the exosomes provided herein are produced by placenta-derived adherent cells that have been cultured in vitro for, e.g., 1, 2, 3, 4, 5, 6 or more passages.
    Type: Application
    Filed: October 8, 2015
    Publication date: September 7, 2017
    Applicant: Anthrogenesis Corporation
    Inventors: Eric LAW, Andrew MORSCHAUSER, Aleksandar FRANCKI, Jennifer PAREDES, Kathy E. KARASIEWICZ-MENDEZ, Allan REDUTA, Vladimir JANKOVIC, Ivana DJURETIC
  • Publication number: 20170160813
    Abstract: Methods, computing devices, and computer-program products are provided for implementing a virtual personal assistant. In various implementations, a virtual personal assistant can be configured to receive sensory input, including at least two different types of information. The virtual personal assistant can further be configured to determine semantic information from the sensory input, and to identify a context-specific framework. The virtual personal assistant can further be configured to determine a current intent. Determining the current intent can include using the semantic information and the context-specific framework. The virtual personal assistant can further be configured to determine a current input state. Determining the current input state can include using the semantic information and one or more behavioral models. The behavioral models can include one or more interpretations of previously-provided semantic information.
    Type: Application
    Filed: October 24, 2016
    Publication date: June 8, 2017
    Applicant: SRI International
    Inventors: Ajay Divakaran, Amir Tamrakar, Girish Acharya, William Mark, Greg Ho, Jihua Huang, David Salter, Edgar Kalns, Michael Wessel, Min Yin, James Carpenter, Brent Mombourquette, Kenneth Nitz, Elizabeth Shriberg, Eric Law, Michael Frandsen, Hyong-Gyun Kim, Cory Albright, Andreas Tsiartas
  • Publication number: 20170002322
    Abstract: Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection.
    Type: Application
    Filed: September 12, 2016
    Publication date: January 5, 2017
    Applicant: Anthrogenesis Corporation
    Inventors: Robert J. HARIRI, Mohammad A. HEIDARAN, Stephen JASKO, Lin KANG, Eric LAW, Ajai PAL, Bhavani STOUT, Vanessa VOSKINARIAN-BERSE, Andrew ZEITLIN, Xiaokui ZHANG
  • Publication number: 20160361366
    Abstract: Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
    Type: Application
    Filed: October 22, 2015
    Publication date: December 15, 2016
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Aleksandr Kaplunovsky, Vladimir Jankovic, Kristen Labazzo, Eric Law, Neerav Padliya, Jennifer Paredes, Jia-Lun Wang
  • Patent number: 9464274
    Abstract: Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: October 11, 2016
    Assignee: Anthrogenesis Corporation
    Inventors: Robert J. Hariri, Mohammad A. Heidaran, Stephen Jasko, Lin Kang, Eric Law, Ajai Pal, Bhavani Stout, Vanessa Voskinarian-Berse, Andrew Zeitlin, Xiaokui Zhang
  • Publication number: 20160106784
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Application
    Filed: December 22, 2015
    Publication date: April 21, 2016
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang
  • Patent number: 9254302
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: February 9, 2016
    Assignee: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang